PAK5 and renal cell carcinoma: Hsa-mir-106a was reported to have reduced expression in renal cell carcinoma cells and tissues, and it was proven that the inhibition of hsa-mir-106a expression can enhance cancer cell migration and invasion through interacting with PAK5 (45).